Mirtazapine Powder

1. Condensation Reaction: Preparation of 2-(4-methyl-2-phenyl-1-piperazinyl)-3-cyanopyridine (Intermediate I)

Using 2-chloro-3-cyanopyridine and 1-methyl-3-phenylpiperazine as raw materials, a nucleophilic substitution reaction is carried out in anhydrous polar solvents (N,N-Dimethylformamide, DMF or Dimethyl Sulfoxide, DMSO).

Reaction conditions: Under nitrogen protection, potassium carbonate is added as an acid-binding agent to neutralize generated HCl. The mixture is heated to 80–90 ℃ and stirred for 6–8 hours, with the reaction progress monitored by TLC.

After the reaction, the mixture is cooled to room temperature, the solvent is removed under reduced pressure, and water is added to precipitate solids. Filtration and drying yield Intermediate I with a yield of approximately 80%, which can be directly used in the next step without purification.

2. Catalytic Reduction Reaction: Preparation of 2-(4-methyl-2-phenyl-1-piperazinyl)-3-hydroxymethylpyridine (Intermediate II)

The cyano group (-CN) of Intermediate I is catalytically reduced to a hydroxymethyl group (-CH₂OH) using Raney-Ni as the catalyst and sodium hypophosphite as the reducing agent, with a mixed solvent system of water/acetic acid/pyridine.Reaction conditions: The temperature is controlled at 50–60 ℃, and the mixture is stirred for 4–6 hours until complete conversion of raw materials is confirmed by TLC.

After the reaction, the catalyst is removed by filtration, the filtrate is concentrated under reduced pressure, and solids are precipitated upon cooling. Filtration and drying afford Intermediate II with a yield of about 85%, and the crude product is directly used for the next step. This step selectively reduces cyano groups without affecting the structures of the piperazine ring and benzene ring, avoiding side reactions.

3. Borohydride Reduction: Preparation of 1-(3-hydroxymethylpyridin-2-yl)-2-phenyl-4-methylpiperazine (Intermediate III)

Trace aldehyde impurities remaining in Intermediate II are selectively reduced to alcoholic hydroxyl groups by sodium borohydride (NaBH₄), with methanol or ethanol as the solvent.Reaction conditions: Stir at room temperature for 2–3 hours to avoid excessive reduction caused by high temperature.

After the reaction, the solvent is evaporated under reduced pressure, water is added for extraction, and the organic layer is dried and concentrated to obtain Intermediate III with a yield of around 90%, which is directly applied to the cyclization reaction without purification.

4. Dehydration Cyclization Reaction: Preparation of Crude Mirtazapine

Intramolecular dehydration cyclization of Intermediate III occurs in concentrated sulfuric acid to construct the tetracyclic parent nucleus and generate mirtazapine.Reaction conditions: Intermediate III is added portionwise into concentrated sulfuric acid, the temperature is maintained at 50–60 ℃, and the mixture is stirred for 8–12 hours until complete cyclization is monitored by TLC.

After the reaction, the solution is cooled to room temperature, slowly poured into ice water, and ammonia water is added to adjust the pH to neutral. Crude mirtazapine is precipitated, filtered, washed with water to neutrality and dried, with a yield of about 85%.

The crude product is purified by activated carbon decolorization combined with recrystallization, using ethanol-water mixed solvent or petroleum ether-ethanol mixed solvent as the recrystallization system.Procedure: Dissolve the crude product in hot ethanol, add activated carbon for reflux decolorization for 30 minutes, filter while hot, and cool the filtrate for crystallization.

Filtration and drying yield refined mirtazapine with purity ≥99.5%, meeting pharmaceutical grade standards. The product is obtained after crushing, with an overall process yield of about 71.5%.